site by C9DD
investment decisions
assessing NPV
Using our wide specialist knowledge of healthcare systems, your knowledge of the product and the market, currently available data on costs and effectiveness of existing treatments approaches and those implied by a new product or service, and sometimes qualitative techniques to establish the views of key decision makers and stakeholders, we can assess for each EU country of interest:
- the size of the market;
- competitor products and alternative treatment approaches;
- relevant codes and likely changes to the reimbursement system;
- the chances of successfully overcoming the ‘fourth hurdle’;
- likely management or payor resistance to the offering;
- likely support or opposition from prescribers;
- likely support from patient groups and the media;
- likely market share;
- likely speed of adoption.
We use this information to model the revenue in future years in each market of interest, including a range to reflect any uncertainties in the market and in the performance of the product or service. This allows us to generate a net present value which, adjusted for the probability of success, allows fully informed investment decisions to be made.